SCHEMBL936426

SCHEMBL936426

C=Cc1ccc(-c2cc(-c3cccc(C(=O)OC)c3)no2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
PRKD1 Q15139 5/20 0.45
ERN1 O75460 1/20 0.44
PPARG P37231 2/20 0.43
PPARA Q07869 2/20 0.43
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
PIK3CG P48736 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL937384 0.89 ALDH1A1 (0.51) TP53MAPTNPC1RAB9APRKD1
SCHEMBL5209891 0.86 NPC1 (0.57) TP53MAPTNPC1RAB9APPARG
SCHEMBL959372 0.85 TP53 (0.65) TP53MAPTNPC1RAB9APRKD1
SCHEMBL937517 0.85 NPC1 (0.59) TP53MAPTNPC1RAB9APRKD1
SCHEMBL12171803 0.84 NPC1 (0.65) TP53MAPTNPC1RAB9APTGS2
SCHEMBL1505201 0.84 NPC1 (0.58) TP53MAPTNPC1RAB9APPARG
SCHEMBL12171384 0.84 NPC1 (0.52) TP53MAPTNPC1RAB9APRKD1
SCHEMBL960012 0.83 NPC1 (0.52) TP53MAPTNPC1RAB9APRKD1
SCHEMBL12171453 0.82 TP53 (0.48) TP53MAPTNPC1RAB9APRKD1
SCHEMBL12171582 0.82 MAPT (0.53) TP53MAPTNPC1RAB9APRKD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed